Published in Br J Haematol on September 01, 2005
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity. Blood (2007) 1.60
The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. Clin Cancer Res (2016) 0.77
Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation. Neoplasia (2017) 0.75
Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells. Clin Cancer Res (2017) 0.75
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell (2008) 2.87
High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. J Clin Oncol (2003) 2.65
Neutrophil granules: a library of innate immunity proteins. Trends Immunol (2007) 2.55
NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. Genes Dev (2008) 2.26
Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity (2002) 2.18
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance. Br J Haematol (2002) 2.07
Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol (2003) 1.88
The transcriptional program of terminal granulocytic differentiation. Blood (2004) 1.80
Mutation update on the CHD7 gene involved in CHARGE syndrome. Hum Mutat (2012) 1.74
Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors. Blood (2004) 1.57
European Myeloma Network recommendations on the evaluation and treatment of newly diagnosed patients with multiple myeloma. Haematologica (2014) 1.57
Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine Tob Res (2003) 1.51
The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes. Blood (2007) 1.35
Loss of C/EBP alpha cell cycle control increases myeloid progenitor proliferation and transforms the neutrophil granulocyte lineage. J Exp Med (2005) 1.33
A bistable switch and anatomical site control Vibrio cholerae virulence gene expression in the intestine. PLoS Pathog (2010) 1.32
HemaExplorer: a database of mRNA expression profiles in normal and malignant haematopoiesis. Nucleic Acids Res (2012) 1.29
Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation. Blood (2006) 1.27
Arginase 1 is expressed in myelocytes/metamyelocytes and localized in gelatinase granules of human neutrophils. Blood (2007) 1.26
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis. Blood (2012) 1.11
Intramyocardial injection of vascular endothelial growth factor-A165 plasmid followed by granulocyte-colony stimulating factor to induce angiogenesis in patients with severe chronic ischaemic heart disease. Eur Heart J (2006) 1.10
Comparing cancer vs normal gene expression profiles identifies new disease entities and common transcriptional programs in AML patients. Blood (2013) 1.09
Identification of p.A684V missense mutation in the WFS1 gene as a frequent cause of autosomal dominant optic atrophy and hearing impairment. Am J Med Genet A (2011) 1.09
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica (2004) 1.05
Identification of translocation products but not K-RAS mutations in memory B cells from patients with multiple myeloma. Haematologica (2010) 1.04
The in vivo toxicity of hydroxyurea depends on its direct target catalase. J Biol Chem (2010) 0.99
Expression of HOXA genes in patients with multiple myeloma. Leuk Lymphoma (2004) 0.98
Comparison of the effects of combined nicotine replacement therapy vs. cigarette smoking in males. Nicotine Tob Res (2003) 0.97
In multiple myeloma clonotypic CD38- /CD19+ / CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes. Leuk Lymphoma (2004) 0.97
Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma. Ann Hematol (2005) 0.97
Smoking cessation or reduction with nicotine replacement therapy: a placebo-controlled double blind trial with nicotine gum and inhaler. BMC Public Health (2009) 0.96
Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs. Haematologica (2011) 0.96
Loss of MicroRNA targets in the 3' untranslated region as a mechanism of retroviral insertional activation of growth factor independence 1. J Virol (2009) 0.92
Myeloma cell expression of 10 candidate genes for osteolytic bone disease. Only overexpression of DKK1 correlates with clinical bone involvement at diagnosis. Br J Haematol (2007) 0.92
Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma. Br J Haematol (2007) 0.92
Neutrophils and keratinocytes in innate immunity--cooperative actions to provide antimicrobial defense at the right time and place. J Leukoc Biol (2004) 0.92
Highly glycosylated alpha1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophils. J Leukoc Biol (2005) 0.90
Idiotype vaccination in multiple myeloma induced a reduction of circulating clonal tumor B cells. Blood (2003) 0.90
Multiplex reverse transcription polymerase chain reaction screening in acute myeloid leukemia detects cytogenetically unrevealed abnormalities of prognostic significance. Haematologica (2005) 0.88
MicroRNA profiling in human neutrophils during bone marrow granulopoiesis and in vivo exudation. PLoS One (2013) 0.88
Pain and somatosensory findings in patients 3 years after total hip arthroplasty. Eur J Pain (2008) 0.86
MyelomA Genetics International Consortium. Leuk Lymphoma (2012) 0.86
Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen. Blood (2008) 0.85
Technical advance: immunophenotypical characterization of human neutrophil differentiation. J Leukoc Biol (2011) 0.85
Anemia and erythropoiesis-stimulating agent administration in patients with non-Hodgkin lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisolone ± rituximab chemotherapy: results from an observational study. Leuk Lymphoma (2011) 0.84
Differential expression of CD56 and CD44 in the evolution of extramedullary myeloma. Br J Haematol (2002) 0.84
The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils. J Leukoc Biol (2008) 0.84
Development and progression of coronary artery calcification in long-term smokers: adverse effects of continued smoking. J Am Coll Cardiol (2013) 0.84
Cognitive dysfunction following desflurane versus sevoflurane general anesthesia in elderly patients: a randomized controlled trial. Med Gas Res (2014) 0.82
Efficacy and safety of CD34-selected and CD19-depleted autografting in multiple myeloma patients: a pilot study. Exp Hematol (2002) 0.82
Myeloma plasma cell expression of osteoblast regulatory genes: overexpression of SFRP3 correlates with clinical bone involvement at diagnosis. Leuk Lymphoma (2012) 0.81
Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition. BMC Bioinformatics (2014) 0.81
Serum YKL-40 concentrations in newly diagnosed multiple myeloma patients and YKL-40 expression in malignant plasma cells. Eur J Haematol (2006) 0.81
Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma. Leuk Lymphoma (2009) 0.81
Characterization of potential CD138 negative myeloma "stem cells". Haematologica (2012) 0.80
Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor. Brief Bioinform (2014) 0.80
C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance. Leuk Lymphoma (2003) 0.80
Optic nerve histopathology in a case of Wolfram Syndrome: a mitochondrial pattern of axonal loss. Mitochondrion (2013) 0.79
Phosphorylation of serine 248 of C/EBPα is dispensable for myelopoiesis but its disruption leads to a low penetrant myeloid disorder with long latency. PLoS One (2012) 0.79
Stable phenotype of B-cell subsets following cryopreservation and thawing of normal human lymphocytes stored in a tissue biobank. Cytometry B Clin Cytom (2014) 0.78
Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study. Eur J Haematol (2003) 0.78
The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome. Mov Disord (2012) 0.77
Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities. Br J Haematol (2003) 0.77
Two new cases with microdeletion of 17q23.2 suggest presence of a candidate gene for sensorineural hearing loss within this region. Am J Med Genet A (2011) 0.77
Impact of 18F-fluorodeoxyglucose positron emission tomography/computed tomography staging in newly diagnosed classical Hodgkin lymphoma: fewer cases with stage I disease and more with skeletal involvement. Leuk Lymphoma (2014) 0.77
Measurements of pericardial adipose tissue using contrast enhanced cardiac multidetector computed tomography--comparison with cardiac magnetic resonance imaging. Int J Cardiovasc Imaging (2013) 0.77
Homoplasmy of the G7444A mtDNA and heterozygosity of the GJB2 c.35delG mutations in a family with hearing loss. Int J Pediatr Otorhinolaryngol (2010) 0.77
Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia. Cytometry B Clin Cytom (2012) 0.77
Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes. Leuk Res (2013) 0.76
The CD19 compartment in myeloma includes a population of clonal cells persistent after high-dose treatment. Leuk Lymphoma (2002) 0.76
Rapidly progressive renal disease as part of Wolfram syndrome in a large inbred Turkish family due to a novel WFS1 mutation (p.Leu511Pro). Eur J Med Genet (2011) 0.76
GJB2 (Connexin-26) mutations are not frequent among hearing impaired patients in east Greenland. Int J Audiol (2012) 0.76
FGFR3 dysregulation and clinical outcome in myeloma. Br J Haematol (2003) 0.75
A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells. BMC Genomics (2012) 0.75
Upregulated MCL1 mRNA expression in multiple myeloma lacks association with survival. Br J Haematol (2008) 0.75
Alternative pre-mRNA splicing leads to potential biomarkers in diffuse large B-cell lymphoma - a systematic review. Dan Med J (2016) 0.75
The relationship of intravenous dextrose administration during emergence from anesthesia to postoperative nausea and vomiting: a randomized controlled trial. Anesth Analg (2013) 0.75
[Mesenchymal stem cell therapy--the key to regenerative medicine?]. Ugeskr Laeger (2003) 0.75
[Complete remission after Rituximab treatment in refractory hairy cell leukemia]. Ugeskr Laeger (2008) 0.75
[Acute lymphoblastic leukaemia in Danish children and young people 10 to 19 years of age. Should young adults with acute lymphoblastic leukaemia be treated in the same way as children?]. Ugeskr Laeger (2006) 0.75
Prediction of haemorrhage in the early stage of acute myeloid leukaemia by flow cytometric analysis of platelet function. Br J Haematol (2005) 0.75